309 related articles for article (PubMed ID: 33712244)
1. Cannabinoid Hyperemesis Syndrome: A Review of the Presentation and Treatment.
Leu N; Routsolias JC
J Emerg Nurs; 2021 May; 47(3):483-486. PubMed ID: 33712244
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid hyperemesis syndrome.
Galli JA; Sawaya RA; Friedenberg FK
Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Hickey JL; Witsil JC; Mycyk MB
Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
[TBL] [Abstract][Full Text] [Related]
4. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Khattar N; Routsolias JC
Am J Ther; 2018; 25(3):e357-e361. PubMed ID: 28953512
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
Dosani K; Koletic C; Alhosh R
Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
[TBL] [Abstract][Full Text] [Related]
6. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
Inayat F; Virk HU; Ullah W; Hussain Q
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
[TBL] [Abstract][Full Text] [Related]
7. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Lee C; Greene SL; Wong A
Clin Toxicol (Phila); 2019 Sep; 57(9):773-777. PubMed ID: 30729854
[No Abstract] [Full Text] [Related]
8. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
Kast KA; Gershengoren L
J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
[TBL] [Abstract][Full Text] [Related]
10. [Spontaneuos pneumomediastinum secondary to cannabinoid hyperemesis syndrome].
Hernández-Ramos I; Parra-Esquivel P; López-Hernández Á; Burillo-Putze G
An Sist Sanit Navar; 2019 Aug; 42(2):227-230. PubMed ID: 31133765
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid hyperemesis syndrome.
Heise L
Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid hyperemesis: a case series.
Donnino MW; Cocchi MN; Miller J; Fisher J
J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
[TBL] [Abstract][Full Text] [Related]
13. [Cannabinoid hyperemesis syndrome: A review of the literature].
Desjardins N; Stheneur C
Arch Pediatr; 2016 Jun; 23(6):619-23. PubMed ID: 27017363
[TBL] [Abstract][Full Text] [Related]
14. Hair cannabinoid concentrations in emergency patients with cannabis hyperemesis syndrome.
Albert K; Sivilotti MLA; Gareri J; Day A; Ruberto AJ; Hookey LC
CJEM; 2019 Jul; 21(4):477-481. PubMed ID: 30806339
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
Graham J; Barberio M; Wang GS
Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.
Lapoint J; Meyer S; Yu CK; Koenig KL; Lev R; Thihalolipavan S; Staats K; Kahn CA
West J Emerg Med; 2018 Mar; 19(2):380-386. PubMed ID: 29560069
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.
Richards JR; Lapoint JM; Burillo-Putze G
Clin Toxicol (Phila); 2018 Jan; 56(1):15-24. PubMed ID: 28730896
[TBL] [Abstract][Full Text] [Related]
18. An analysis of cannabinoid hyperemesis syndrome Reddit posts and themes.
Wightman RS; Perrone J; Collins AB; Lakamana S; Sarker A
Clin Toxicol (Phila); 2023 Apr; 61(4):283-289. PubMed ID: 37014024
[TBL] [Abstract][Full Text] [Related]
19. [Cannabinoid hyperemesis syndrome].
Stuijvenberg MP; Ramaekers GM; Bijpost Y
Ned Tijdschr Geneeskd; 2011; 155():A2880. PubMed ID: 21426598
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE-4): Alcohol use disorder and cannabinoid hyperemesis syndrome management in the emergency department.
Borgundvaag B; Bellolio F; Miles I; Schwarz ES; Sharif S; Su MK; Baumgartner K; Liss DB; Sheikh H; Vogel J; Austin EB; Upadhye S; Klaiman M; Vellend R; Munkley A; Carpenter CR
Acad Emerg Med; 2024 May; 31(5):425-455. PubMed ID: 38747203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
